Trial Profile
A Randomized, Placebo-Controlled Double-Blind Trial Using Sitagliptin as a Treatment to Prevent New Onset Diabetes After Kidney Transplantation: A Pilot Study
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 18 Sep 2023
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 12 Jan 2018 Status changed from recruiting to discontinued.
- 15 Jul 2009 New trial record